Moderna to seek regulatory approval for its Covid-19 vaccine in US and EU
The biotech group follows Pfizer in seeking approval and plans to distribute its vaccine in December
30 November 2020 - 16:42
Moderna plans to request clearance for its coronavirus vaccine in the US and Europe on Monday, after a new analysis showed the vaccine was highly effective in preventing Covid-19, with no serious safety problems.
The primary analysis, which included 196 cases, found the vaccine was 94.1% effective, in line with preliminary findings released earlier in November. All 30 severe cases observed in the study occurred in participants who received a placebo, according to a company statement, indicating 100% efficacy against severe disease for the shot...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.